JK-1Homo sapiens (Human)Cancer cell line

Also known as: JK1

🤖 AI SummaryBased on 8 publications

Quick Overview

JK-1 is a human chronic myeloid leukemia cell line derived from a patient with Philadelphia chromosome-positive disease.

Detailed Summary

JK-1 is a human chronic myeloid leukemia (CML) cell line established from a patient with Philadelphia chromosome-positive CML. It is characterized by the presence of the BCR-ABL fusion gene, which results from the t(9;22)(q34;q11) translocation. This cell line is widely used in research to study the molecular mechanisms of CML and the effects of targeted therapies such as tyrosine kinase inhibitors. JK-1 has been utilized in studies investigating the genetic and molecular alterations associated with CML progression and drug resistance. It is also part of the Cancer Cell Line Encyclopedia (CCLE) and has been used in various genomic and pharmacological studies to identify biomarkers and therapeutic targets.

Research Applications

Study of BCR-ABL fusion gene and its role in CMLInvestigation of tyrosine kinase inhibitor resistanceGenomic and pharmacological profilingIdentification of biomarkers and therapeutic targets

Key Characteristics

Presence of Philadelphia chromosome (t(9;22)(q34;q11))Expression of BCR-ABL fusion proteinUsed in studies of CML progression and drug resistance
Generated on 6/18/2025

Basic Information

Database IDCVCL_2079
SpeciesHomo sapiens (Human)

Donor Information

Age58
Age CategoryAdult
SexMale
Subtype FeaturesBCR-ABL1 positive

Disease Information

DiseaseChronic myeloid leukemia
LineageMyeloid
SubtypeChronic Myeloid Leukemia, BCR-ABL1+
OncoTree CodeCMLBCRABL1

DepMap Information

Source TypeDSMZ
Source IDACH-000241_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
Gene fusionABL1BCR-ABL1, BCR-ABL-BCR exon 1 fused to ABL1 exon 2PubMed=10576511, PubMed=10071072, PubMed=8751477

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
11
D13S317
9,13
D16S539
9,13
D18S51
14,19
D19S433
14
D21S11
29,31
D2S1338
17,19
D3S1358
17
D5S818
11
D7S820
13
D8S1179
12,13
FGA
21,25
Penta D
11,14
Penta E
16,18
TH01
6,9
TPOX
8,11
vWA
18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Screening human cell lines for viral infections applying RNA-Seq data analysis.

Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.

PLoS ONE 14:E0210404-E0210404(2019).

Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.

Yang H.H., Koeffler H.P.

BMC Cancer 18:940.1-940.13(2018).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Genomic amplification of BCR/ABL1 and a region downstream of ABL1 in chronic myeloid leukaemia: a FISH mapping study of CML patients and cell lines.

Virgili A., Nacheva E.

Mol. Cytogenet. 3:15.1-15.12(2010).

JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.

Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.

Leukemia 20:471-476(2006).

Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.

Fioretos T.

Leukemia 19:1042-1050(2005).

ABL-BCR expression in BCR-ABL-positive human leukemia cell lines.";

Uphoff C.C., Habig S., Fombonne S., Matsuo Y., Drexler H.G.

Leuk. Res. 23:1055-1060(1999).

Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.

Drexler H.G., MacLeod R.A.F., Uphoff C.C.

Leuk. Res. 23:207-215(1999).

Establishment of an erythroid cell line (JK-1) that spontaneously differentiates to red cells.

Sasaki R., Tada K., Imura H.

Cancer 66:1544-1551(1990).

The leukemia-lymphoma cell line factsbook.";

Drexler H.G.

(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).